Back
Day Range
$48.06
$50.60
52-Week Range
$20.44
$118.84
Volume
715,563
50D / 200D Avg
$79.67
/
$65.69
Prev Close
$46.84
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.9 | 0.4 |
| P/B | 0.8 | 2.9 |
| ROE % | -16.1 | 3.8 |
| Net Margin % | -277.5 | 3.9 |
| Rev Growth 5Y % | 78.2 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 78.15% annually over 5 years — strong growth
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -299.01M
PEG of 0.09 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 60.97%
Capital efficient — spends only 0.62% of revenue on capex
Growth
Revenue Growth (5Y)
78.15%
Revenue (1Y)17.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-16.07%
ROIC-14.97%
Net Margin-277.47%
Op. Margin-362.95%
Safety
Debt / Equity
0.04
Current Ratio11.97
Interest Coverage0.00
Valuation
P/E Ratio
-4.94
P/B Ratio0.78
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.18% | Revenue Growth (3Y) | 25.73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 78.15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 147.17M | Net Income (TTM) | -408.35M |
| ROE | -16.07% | ROA | -13.97% |
| Gross Margin | -42.52% | Operating Margin | -362.95% |
| Net Margin | -277.47% | Free Cash Flow (TTM) | -299.01M |
| ROIC | -14.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 11.97 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.94 | P/B Ratio | 0.78 |
| P/S Ratio | 13.69 | PEG Ratio | 0.09 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.02B | Enterprise Value | 1.86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 147.17M | 125.60M | 93.11M | 55.55M | 14.61M |
| Net Income | -408.35M | -2.03B | -1.47B | -5.40B | -1.25B |
| EPS (Diluted) | -11.11 | -63.54 | -47.20 | -173.87 | -40.18 |
| Gross Profit | -62.57M | -78.02M | -95.61M | -116.45M | -100.00M |
| Operating Income | -534.16M | -2.19B | -1.52B | -5.44B | -1.27B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.92B | 2.98B | 4.56B | 5.60B | 9.74B |
| Total Liabilities | 344.15M | 479.90M | 910.74M | 955.94M | 307.40M |
| Shareholders' Equity | 2.58B | 2.50B | 3.65B | 4.65B | 9.43B |
| Total Debt | 98.01M | 68.14M | 84.41M | 96.01M | 110.56M |
| Cash & Equivalents | 249.73M | 214.23M | 97.29M | 241.60M | 221.16M |
| Current Assets | 953.85M | 819.86M | 156.07M | 295.63M | 242.73M |
| Current Liabilities | 79.67M | 76.93M | 163.61M | 134.94M | 97.89M |